| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H22Cl2N2O4 |
| Molecular Weight | 305.199 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H](CNCCCl)[C@@H](O)[C@H](O)[C@H](O)CNCCCl
InChI
InChIKey=MQXVYODZCMMZEM-ZYUZMQFOSA-N
InChI=1S/C10H22Cl2N2O4/c11-1-3-13-5-7(15)9(17)10(18)8(16)6-14-4-2-12/h7-10,13-18H,1-6H2/t7-,8-,9-,10-/m1/s1
| Molecular Formula | C10H22Cl2N2O4 |
| Molecular Weight | 305.199 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Mannomustine is a substance synthesized as one of a series of compounds linking the actively cytotoxic chemical group beta-chlorethylamine with a naturally
occurring substance, mannitol. Mannomustine is an alkylating agent with antineoplastic properties. It was being studied in the treatment of hematologic malignancies.
Originator
Approval Year
PubMed
|
|
SALT/SOLVATE -> PARENT |
Showing 1 to 1 of 1 entries
